Cargando…

An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand

BACKGROUND: The aim of this study was to assess the psychometric properties, namely acceptability, validity, reliability, interpretability and responsiveness of the EuroQol EQ-5D (EQ-5D visual analogue (VAS) and EQ-5D (utility)), Short Form 12 Dimensions (SF-12), SF-6D and Michigan Hand Outcome Ques...

Descripción completa

Detalles Bibliográficos
Autores principales: Dritsaki, Melina, Petrou, Stavros, Williams, Mark, Lamb, Sarah E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259980/
https://www.ncbi.nlm.nih.gov/pubmed/28118833
http://dx.doi.org/10.1186/s12955-016-0584-6
_version_ 1782499316454129664
author Dritsaki, Melina
Petrou, Stavros
Williams, Mark
Lamb, Sarah E.
author_facet Dritsaki, Melina
Petrou, Stavros
Williams, Mark
Lamb, Sarah E.
author_sort Dritsaki, Melina
collection PubMed
description BACKGROUND: The aim of this study was to assess the psychometric properties, namely acceptability, validity, reliability, interpretability and responsiveness of the EuroQol EQ-5D (EQ-5D visual analogue (VAS) and EQ-5D (utility)), Short Form 12 Dimensions (SF-12), SF-6D and Michigan Hand Outcome Questionnaire (MHQ) in patients with rheumatoid arthritis (RA) of the hand. METHODS: The empirical investigation was based upon data from a randomised controlled trial of 488 adults with rheumatoid arthritis who had pain and dysfunction of the hands and/or wrists. Participants completed the EQ-5D, SF-12 and MHQ at baseline and at 4 and 12 months follow up. Acceptability was measured using completion rates over time; construct validity using the “known groups” approach, based on pain troublesomeness; convergent validity using spearman’s rho correlation (ρ); reliability using internal consistency (Cronbach’s alpha); interpretability using minimal important differences (MID); and responsiveness using effect sizes and standardised response means (SRM) stratified by level of self-rated improvement in hand and wrist function or level of self-rated benefit and satisfaction from trial treatments. RESULTS: At baseline, the study population had a mean age of 62.4 years, a mean MHQ score of 52.1 and included 76% women. The EQ-5D (utility) had the highest completion rates across time points. All instruments discriminated between pre-specified groups based on pain troublesomeness. Convergent validity analysis indicated that the MHQ score correlated strongly with the EQ-5D (ρ = 0.65) and SF-6D (ρ = 0.63) utility scores. The MHQ was most responsive at detecting change in indicators of RA pain severity between baseline and 4 months, whilst minimal important differences varied considerably across PROMs. CONCLUSIONS: The instruments evaluated in this study displayed varying psychometric properties in the context of RA of the hand. The selection of a preferred instrument in evaluative studies should ultimately depend on the relative importance placed on individual psychometric properties and the importance placed on generation of health utilities for economic evaluation purposes.
format Online
Article
Text
id pubmed-5259980
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52599802017-01-26 An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand Dritsaki, Melina Petrou, Stavros Williams, Mark Lamb, Sarah E. Health Qual Life Outcomes Research BACKGROUND: The aim of this study was to assess the psychometric properties, namely acceptability, validity, reliability, interpretability and responsiveness of the EuroQol EQ-5D (EQ-5D visual analogue (VAS) and EQ-5D (utility)), Short Form 12 Dimensions (SF-12), SF-6D and Michigan Hand Outcome Questionnaire (MHQ) in patients with rheumatoid arthritis (RA) of the hand. METHODS: The empirical investigation was based upon data from a randomised controlled trial of 488 adults with rheumatoid arthritis who had pain and dysfunction of the hands and/or wrists. Participants completed the EQ-5D, SF-12 and MHQ at baseline and at 4 and 12 months follow up. Acceptability was measured using completion rates over time; construct validity using the “known groups” approach, based on pain troublesomeness; convergent validity using spearman’s rho correlation (ρ); reliability using internal consistency (Cronbach’s alpha); interpretability using minimal important differences (MID); and responsiveness using effect sizes and standardised response means (SRM) stratified by level of self-rated improvement in hand and wrist function or level of self-rated benefit and satisfaction from trial treatments. RESULTS: At baseline, the study population had a mean age of 62.4 years, a mean MHQ score of 52.1 and included 76% women. The EQ-5D (utility) had the highest completion rates across time points. All instruments discriminated between pre-specified groups based on pain troublesomeness. Convergent validity analysis indicated that the MHQ score correlated strongly with the EQ-5D (ρ = 0.65) and SF-6D (ρ = 0.63) utility scores. The MHQ was most responsive at detecting change in indicators of RA pain severity between baseline and 4 months, whilst minimal important differences varied considerably across PROMs. CONCLUSIONS: The instruments evaluated in this study displayed varying psychometric properties in the context of RA of the hand. The selection of a preferred instrument in evaluative studies should ultimately depend on the relative importance placed on individual psychometric properties and the importance placed on generation of health utilities for economic evaluation purposes. BioMed Central 2017-01-24 /pmc/articles/PMC5259980/ /pubmed/28118833 http://dx.doi.org/10.1186/s12955-016-0584-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Dritsaki, Melina
Petrou, Stavros
Williams, Mark
Lamb, Sarah E.
An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
title An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
title_full An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
title_fullStr An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
title_full_unstemmed An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
title_short An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
title_sort empirical evaluation of the sf-12, sf-6d, eq-5d and michigan hand outcome questionnaire in patients with rheumatoid arthritis of the hand
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259980/
https://www.ncbi.nlm.nih.gov/pubmed/28118833
http://dx.doi.org/10.1186/s12955-016-0584-6
work_keys_str_mv AT dritsakimelina anempiricalevaluationofthesf12sf6deq5dandmichiganhandoutcomequestionnaireinpatientswithrheumatoidarthritisofthehand
AT petroustavros anempiricalevaluationofthesf12sf6deq5dandmichiganhandoutcomequestionnaireinpatientswithrheumatoidarthritisofthehand
AT williamsmark anempiricalevaluationofthesf12sf6deq5dandmichiganhandoutcomequestionnaireinpatientswithrheumatoidarthritisofthehand
AT lambsarahe anempiricalevaluationofthesf12sf6deq5dandmichiganhandoutcomequestionnaireinpatientswithrheumatoidarthritisofthehand
AT dritsakimelina empiricalevaluationofthesf12sf6deq5dandmichiganhandoutcomequestionnaireinpatientswithrheumatoidarthritisofthehand
AT petroustavros empiricalevaluationofthesf12sf6deq5dandmichiganhandoutcomequestionnaireinpatientswithrheumatoidarthritisofthehand
AT williamsmark empiricalevaluationofthesf12sf6deq5dandmichiganhandoutcomequestionnaireinpatientswithrheumatoidarthritisofthehand
AT lambsarahe empiricalevaluationofthesf12sf6deq5dandmichiganhandoutcomequestionnaireinpatientswithrheumatoidarthritisofthehand